Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population

Clinical Therapeutics

Volumn 32, Issue 6, 2010, Pages 1093-1102

  Bollinger, Mary Elizabeth ^a   Diette, Gregory B ^b   Chang, Chun Lan ^c   Stephenson, Judith J ^c   Sajjan, Shiva G ^d   Fan, Tao ^d   Allen Ramey, Felicia C ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HEALTHCORE INC   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Allergic rhinitis; Antihistamines; Intranasal corticosteroids; Managed care; Montelukast; Pharmacy fills

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; MONTELUKAST;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; CHILD; COMORBIDITY; COUGHING; FEMALE; HAY FEVER; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PRESCRIPTION; PRODUCTIVITY; STATISTICAL ANALYSIS; UNITED STATES; WHEEZING;

ACETATES; ADOLESCENT; ADULT; AGE FACTORS; ANTI-ASTHMATIC AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG UTILIZATION; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE, HEALTH; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUINOLINES; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC, SEASONAL; SEX FACTORS; YOUNG ADULT;

EID: 77954637950     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.06.003     Document Type: Article

References (22)

1. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008, 63(Suppl 86):8-160.
2. Dykewicz MS, Fineman S Executive summary ofjoint task force practice parameters on diagnosis and management of rhinitis. Ann Allergy Asthma Immunol. 1998, 81:463-468.
3. Nathan RA The burden of allergic rhinitis. Allergy Asthma Proc. 2007, 28:3-9.
4. Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: Results from the Pediatric Allergies in America survey. J Allergy Clin Immunol. 2009, 124(Suppl 3):S43-S70.
5. Meltzer EO, Nathan R, Derebery J, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: Findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc. 2009, 30:244-254.
6. Schatz M, Zeiger RS, Chen W, et al. The burden of rhinitis in a managed care organization. Ann Allergy Asthma Immunol. 2008, 101:240-247.
7. Skoner DP Allergic rhinitis: Definition, epidemiology, pathophysiology, detection and diagnosis. J Allergy Clin Immunol. 2001, 108(Suppl 1):2-8.
8. Schoenwetter WF, Dupclay L, Appajoysyula S, et al. Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin. 2004, 20:305-317.
9. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol. 2008, 122:S1-S84.
10. Nathan RA, Meltzer EO, Derebery J, et al. The prevelance of nasal symptoms attributed to allergies in the United States: Findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc. 2008, 29:600-608.
11. Sly RM Epidemiology of allergic rhinitis. Clin Rev Allergy Immunol. 2002, 22:67-103.
12. Settipane RA Rhinitis: A dose of epidemiological reality. Allergy Asthma Proc. 2003, 24:147-154.
13. Kay GG The effects of antihistamines on cognition and performance. J Allergy Clin Immunol. 2000, 105:S622-S627.
14. Blaiss MS Cognitive, social, and economic costs of allergic rhinitis. Allergy Asthma Proc. 2000, 21:7-13.
15. Law AW, Reed SD, Sundy JS, Schulman KA Direct costs of allergic rhinitis in the United States: Estimates from the 1996 Medical Expenditure Panel Survey. J Allergy Clin Immunol. 2003, 111:296-300.
16. Bousquet J, Reid J, van Weel C, et al. Allergic rhinitis management pocket reference 2008. Allergy. 2008, 63:990-996.
17. Canonica GW, Bousquet J, Mullol J, et al. A survey of the burden of al- lergic rhinitis in Europe. Allergy. 2007, 62(Suppl 85):17-25.
18. Schatz M A survey of the burden of allergic rhinitis in the USA. Allergy. 2007, 62(Suppl 85):9-16.
19. Nayak A, Langdon RB Montelukast in the treatment of allergic rhinitis: An evidence-based review. Drugs. 2007, 67:887-901.
20. Allergies in America: A landmark survey of nasal allergy sufferers Accessed November 30, 2009. http://www.myallergiesinamerica.com/.
21. Prenner BM, Schenkel E Allergic rhinitis: Treatment based on patient profiles. Am J Med. 2006, 119:230-237.
22. Blaiss M Current concepts and therapeutic strategies for allergic rhinitis in school-age children. Clin Ther. 2004, 26:1876-1889.